Since its development and release in 2019, the Society for Cardiovascular Angiography and
Interventions (SCAI) shock stage classification for adult patients has been widely cited and …

The use of temporary mechanical circulatory support in cardiogenic shock has increased
dramatically despite a lack of randomized controlled trials or evidence guiding clinical …

Background Risk-stratifying patients with cardiogenic shock (CS) is a major unmet need.
The recently proposed Society for Cardiovascular Angiography and Interventions (SCAI) …

Cardiogenic shock accounts for~ 100,000 annual hospital admissions in the United States.
Despite improvements in medical management strategies, in-hospital mortality remains …

Background: Cardiogenic shock occurring in the setting of advanced heart failure (HF-CS) is
increasingly common. However, recent studies have focused almost exclusively on acute …

Despite the rapidly evolving evidence base in modern cardiology, progress in the area of
cardiogenic shock remains slow, with short-term mortality still reaching 40-50%, relatively …

Cardiogenic shock (CS) is a heterogeneous syndrome reflecting a broad spectrum of shock
severity, diverse etiologies, variable cardiac function, different hemodynamic trajectories …

Background Understanding the prognostic impact of right ventricular dysfunction (RVD) in
cardiogenic shock (CS) is a key step toward rational diagnostic and treatment algorithms …

Despite the efforts made to improve the care of cardiogenic shock (CS) patients, including
the development of mechanical circulatory support (MCS), the prognosis of these patients …

Heart failure (HF) prevalence remains high worldwide with significant sex-related and
regional differences in its presentation, management, and outcomes. In 2020, advances in …